Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rousseau

Showing results (31-40 of 524) with videos related to

Pageof 53
Sort By:
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Vaccine therapies for pediatric malignanciesRaphaël F Rousseau, Malcolm K Brenner
The EMBO Journal|May 1, 1993
Evidence for the involvement of PSI-E subunit in the reduction of ferredoxin by photosystem IF Rousseau, P Sétif, B Lagoutte
Anaesthesia|August 18, 2000
Reserve nitrous oxide cylinders on anaesthetic machines. A survey of attitudes and equipment at a large DGHG F Rousseau, A S Carr
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1973
Histiocytosis X histogenetic arguments for a Langerhans cell originC Nezelof, F Basset, M F Rousseau
European Journal of Cancer|August 1, 1974
Behaviour of Wilms tumour and normal metanephros in organ cultureM F Rousseau, B Nabarra, C Nezelof
Human Mutation|January 1, 1992
The unstable and methylatable mutations causing the fragile X syndromeF Rousseau, D Heitz, J L Mandel
European Heart Journal|August 1, 1991
Dopaminergic drugs in the management of chronic heart failureH Pouleur, J Raigoso, M F Rousseau
British Journal of Clinical Pharmacology|January 1, 1989
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitorsH Pouleur, C Hanet, M F Rousseau
Annales D'Anatomie Pathologique|October 1, 1970
[Nephroblastoma. Chromosomal study]M F Rousseau, M Laurent, C Nezelof
European Heart Journal|April 1, 1990
Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunctionH Pouleur, C Hanet, M F Rousseau
Pageof 53

Showing results (31-40 of 524) with videos related to

Sort By:
Pageof 53
Cancer Journal (Sudbury, Mass.)|October 4, 2005
Vaccine therapies for pediatric malignanciesRaphaël F Rousseau, Malcolm K Brenner
The EMBO Journal|May 1, 1993
Evidence for the involvement of PSI-E subunit in the reduction of ferredoxin by photosystem IF Rousseau, P Sétif, B Lagoutte
Anaesthesia|August 18, 2000
Reserve nitrous oxide cylinders on anaesthetic machines. A survey of attitudes and equipment at a large DGHG F Rousseau, A S Carr
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|September 1, 1973
Histiocytosis X histogenetic arguments for a Langerhans cell originC Nezelof, F Basset, M F Rousseau
European Journal of Cancer|August 1, 1974
Behaviour of Wilms tumour and normal metanephros in organ cultureM F Rousseau, B Nabarra, C Nezelof
Human Mutation|January 1, 1992
The unstable and methylatable mutations causing the fragile X syndromeF Rousseau, D Heitz, J L Mandel
European Heart Journal|August 1, 1991
Dopaminergic drugs in the management of chronic heart failureH Pouleur, J Raigoso, M F Rousseau
British Journal of Clinical Pharmacology|January 1, 1989
The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitorsH Pouleur, C Hanet, M F Rousseau
Annales D'Anatomie Pathologique|October 1, 1970
[Nephroblastoma. Chromosomal study]M F Rousseau, M Laurent, C Nezelof
European Heart Journal|April 1, 1990
Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunctionH Pouleur, C Hanet, M F Rousseau
Pageof 53